Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Precision medicine for muscoloskeletal regeneration, prosthetics and active ageing

Project description

New generation trained for musculoskeletal disease treatment

Musculoskeletal diseases are a major burden on individuals, healthcare and welfare systems, and their treatment is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. The EU-funded PREMUROSA project aims to train a new generation of scientists with an integrated vision of the whole value chain in musculoskeletal regeneration technologies. The project will boost an environment of innovations that develop devices and optimised clinical applications using interdisciplinary, intersectoral and international approaches. The new generation of researchers will sharpen their experimental and complementary skills in a well-designed and diversified training programme.

Objective

Muscoloskeletal diseases are a major burden on individuals, healthcare and welfare systems. Treatment of muscolo-skeletal disorders is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. In both cases, individual tissue healing and regeneration, together with the appropriateness of the implanted device, markedly affect the outcome. A great improvement could be achieved by precision medicine, specifically designed on patient’s individual characteristics. This implies to combine the personalized clinical approach with individual ‘omic’ characterization and proper choice of medical device. The concept is “To take care with care”. This is the meaning of the Italian word “premurosa” and the ultimate goal of the ITN PREMUROSA project, aimed to train a new generation of scientists with an integrated vision of the whole value chain in muscolo-skeletal regeneration technologies and able to boost the necessary innovations to achieve precision principles in developing innovative devices and optimized clinical applications. This aim will be achieved by a “triple i” (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field. They will learn to integrate academic and industrial aspects and they will sharpen their experimental and complementary skills in a well-designed and diversified and unprecedented training program.

Coordinator

UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO
Net EU contribution
€ 784 499,04
Address
DUOMO 6
13100 Vercelli
Italy

See on map

Region
Nord-Ovest Piemonte Vercelli
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 784 499,04

Participants (10)